News Column

ACCELERON PHARMA INC FILES (8-K) Disclosing Submission of Matters to a Vote of Security Holders

June 24, 2014



Item 5.07. Submission of Matters to a Vote of Security Holders

On June 20, 2014, Acceleron Pharma Inc. (the "Company") held its previously announced Annual Meeting of Stockholders (the "Meeting"), at which a quorum was present. At the Meeting, the stockholders of the Company voted on the two proposals as follows: (i) to elect Jean M. George, George Golumbeski and Edwin M. Kania as Class I members of the board of directors to serve until the Company's 2017 annual meeting of stockholders and until their successors are duly elected and qualified ("Proposal 1") and (ii) to ratify the selection of Ernst & Young, LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2014 ("Proposal 2").

The Company's stockholders approved Proposal 1. The votes cast at the Annual Meeting were as follows:

On the election of Jean M. George as a Class I director - 24,171,606 shares voted for and 410,924 shares withheld.

On the election of George Golumbeski as a Class I director - 24,564,398 shares voted for and 18,132 shares withheld.

On the election of Edwin M. Kania as a Class I director - 24,577,358 shares voted for and 5,172 shares withheld.

There were no abstentions or broker non-votes with respect to Proposal 1.

The Company stockholders approved Proposal 2. The votes cast at the Annual Meeting were as follows: 24,567,927 shares voted for, 14,603 shares voted against and zero shares abstained from voting. There were no broker non-votes with respect to Proposal 2.

2



--------------------------------------------------------------------------------


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Edgar Glimpses


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters